New IPO Updates | Shenzhen Han'S Cnc Technology (301200.SZ), Kaqiao E-Commerce Among Firms Filing for Hong Kong IPO with CSRC Materials Accepted

Stock News2025-12-08

On December 6, the China Securities Regulatory Commission (CSRC) released its weekly update on overseas securities issuance and listing filings by domestic enterprises (covering initial public offerings and full circulation) as of December 6, 2025. During the week of December 1–6, applications from Shenzhen Han'S Cnc Technology Co.,Ltd. (301200.SZ), Kaqiao E-Commerce, DeepZero AI, and Hemei Pharmaceutical for Hong Kong IPOs were accepted by the CSRC.

According to their prospectuses, Shenzhen Han'S Cnc Technology is a provider of PCB-specific production equipment solutions. The company operates in the PCB equipment sector, supplying core infrastructure to downstream industries such as servers and data storage, automotive electronics, smartphones, computers, and consumer electronics. The majority of its revenue during the track record period was generated from mainland China.

Kaqiao E-Commerce, a digital retail solutions provider, offers comprehensive and customized solutions to brand owners, helping them efficiently establish e-commerce infrastructure, drive online sales, and enhance operational efficiency to accelerate business growth. Its solutions span the entire value chain of the e-commerce ecosystem, including brand positioning, product development consulting, retail operations, channel management, marketing, fulfillment, and data and IT services.

Founded in 2002, Hemei Pharmaceutical is a biopharmaceutical company focused on discovering and developing in-house small-molecule drugs for autoimmune diseases and oncology, with established expertise in Ps, BD, IBD, and chemotherapy development.

DeepZero AI is a China-based decision-making AI technology firm specializing in AI applications for marketing and sales scenarios. According to Frost & Sullivan, the company ranked first in China’s marketing and sales decision-making AI application market by 2024 revenue, holding a 2.6% market share. In China’s broader decision-making AI application market, it ranked fourth by revenue with a 1.6% share due to its extensive scale. During the track record period, its strategic AI applications for marketing and sales included intelligent ad placement and data management, powered by flagship platforms AlphaDesk and AlphaData.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment